Altria Group, Inc.

Q3 2026
Speakers

Oct 29, 2026 · 46 min

PREPARED REMARKS · INFERREDKeys: / search · Space play · ←→ ±10s · [] sections

Prepared remarks

Speaker 0

Unverified voice label

Good day and welcome to the Altria Group 2026 third quarter earnings conference call. Today's call is scheduled to last about one hour, including remarks by Altria's management and a question and answer session. Representatives of the investment community and media on the call will be able to ask questions following the conclusion of prepared remarks. I would now like to turn the call over to Mac Livingston, Vice President of Investor Relations.

Please go ahead,

Passages & reports (2)
  • Good day and welcome to the Altria Group 2026 third quarter earnings conference call. Toda…
  • the conclusion of prepared remarks. I would now like to turn the call over to Mac Livingst…

Speaker unclear

?sir.

Passages & reports (1)
  • sir.

Speaker 1

Unverified voice label

Thanks, Olivia. Good morning, and thank you for joining us. This morning, Salman Cuso, Altria's CEO, and Heather Newman, our CFO, will discuss Altria's 2026 third quarter and first nine months business results. Earlier today, we issued a press release providing our results. The release, presentation, and quarterly metrics are all available at Altria.com. During our call today, unless otherwise stated, we're comparing results to the same period in 2025.

Our remarks contain forward-looking and forward-looking statements, including
projections of future results. Please review the forward looking and cautionary statements section at the end of today's earnings release for various factors that could cause actual results to differ materially from projections. Future dividend payments and share repurchases remain subject to the discretion of our board of directors.

Passages & reports (3)
  • Thanks, Olivia. Good morning, and thank you for joining us. This morning, Salman Cuso, Alt…
  • results. The release, presentation, and quarterly metrics are all available at Altria.com.…
  • projections of future results. Please review the forward looking and cautionary statements…

We report our financial results in accordance with U.S. generally accepted accounting principles. Today's call will contain various operating results on both a reported and adjusted basis. Adjusted results exclude special items that affect comparisons with reported results. Descriptions of these non-GAAP financial measures and reconciliations to the most comparable GAAP financial measures are included in today's earnings release and on our website at Altria.com.

Finally, all references in today's remarks to nicotine consumers or consumers within a specific nicotine
category or segment refer to existing adult nicotine consumers 21 years of age or older. With that, I'll turn the call over to Sal.

Passages & reports (3)
  • We report our financial results in accordance with U.S. generally accepted accounting prin…
  • non-GAAP financial measures and reconciliations to the most comparable GAAP financial meas…
  • category or segment refer to existing adult nicotine consumers 21 years of age or older. W…

Speaker 2

Unverified voice label

Thanks, ?Mac. Good morning, and thank you for joining ?us. Altrea delivered strong financial performance in the third quarter, growing adjusted diluted earnings per share by 4.8%, while continuing to invest in our vision and building on our foundation for the future. In smokable products, PMUSA grew operating companies' income through its data-driven total portfolio approach, with Cowboy Cut strengthening Marble's premium position, and BASIC continuing to gain share and discount.

In smoke free, Kelix made
meaningful progress by expanding on plus twelve milligram nationwide, investing in brand building initiatives, and preparing for its next wave of innovation, which is now underway with the introduction of blueberry mint and mangled pineapple flavor extensions at retail. Our highly cash-generative businesses supported significant returns to shareholders through dividends and share repurchases, while we continued to invest in support of our vision.

In August, we announced our
61st dividend increase in 57 years, and our board recently authorized a $1 billion expansion of our existing share repurchase program. Our strong performance through the first nine months and confidence in our full year plan allowed us to raise our earnings guidance for the year. My remarks this morning will focus on third quarter performance from on and the evolving regulatory environment.

I'll then turn it over to Heather, who will provide further details on our business results and
2026 financial outlook. Let's begin with the nicotine pouch category in our growing on portfolio. Nicotine pouches continue to drive volume growth in the oral tobacco category, which we estimate increased 5.5% over the past six months. In the third quarter, the nicotine pouch category grew 5.8 share points and now represents more than 60% ?of the total oral category.

As the category continues to expand, Helix is delivering solid results and strengthening on's position in an increasingly competitive marketplace.
?In the third quarter, on reported shipment volume increased 13.3% to 47.8 million cans. Year to date, reported shipment volume increased 7.7%.

Passages & reports (16)
  • Thanks,
  • Mac.
  • Good morning, and thank you for joining
  • us.
  • Altrea delivered strong financial performance in the third quarter, growing adjusted dilut…
  • PMUSA grew operating companies' income through its data-driven total portfolio approach, w…
  • meaningful progress by expanding on plus twelve milligram nationwide, investing in brand b…
  • extensions at retail. Our highly cash-generative businesses supported significant returns …
  • 61st dividend increase in 57 years, and our board recently authorized a $1 billion expansi…
  • allowed us to raise our earnings guidance for the year. My remarks this morning will focus…
  • 2026 financial outlook. Let's begin with the nicotine pouch category in our growing on por…
  • over the past six months. In the third quarter, the nicotine pouch category grew 5.8 share…
  • of
  • the total oral category. As the category continues to expand, Helix is delivering solid re…
  • In
  • the third quarter, on reported shipment volume increased 13.3% to 47.8 million cans. Year …

Speaker 2

share was 8.3 percent in the third quarter, up one tenth versus the prior year, and down three-tenths sequentially. This performance is encouraging as on's retail price continued to move higher and competitive investment remained elevated across the category during the quarter. Higher nicotine strengths and broader flavor variety continued to drive growth in the nicotine pouch category. And HELIS is expanding onPlus to better meet this consumer demand. ?

In
the third quarter, HELIX expanded on plus 12 milligrams nationally across mint, winnergreen, and tobacco. And this month introduced blueberry mint and mango pineapple. And we're excited to announce ?that watermelon mint will join the portfolio in select retail locations in November with plans for more flavor innovation to

Passages & reports (6)
  • share was 8.3 percent in the third quarter, up one tenth versus the prior year, and down t…
  • elevated across the category during the quarter. Higher nicotine strengths and broader fla…
  • In
  • the third quarter, HELIX expanded on plus 12 milligrams nationally across mint, winnergree…
  • that
  • watermelon mint will join the portfolio in select retail locations in November with plans …

Speaker unclear

?come.

Passages & reports (1)
  • come.

Speaker 2

We believe these additions strengthened the ONPLUS portfolio and are supporting it with superior retail execution. Earlier this year, Helix launched a retail trade program that secured premium positioning and stores representing approximately 90% of its volume. In an increasingly competitive category, we believe this positioning provides valuable visibility to support awareness, trial, and conversion. Beyond retail, Helix continues to invest in building the on brand and creating distinctive consumer experiences.

Earlier this month, Helix hosted the inaugural on vitational, an invite only golf tournament in Palm Beach, Florida.
?The event gave on consumers the chance to compete alongside athletes and golf personalities. Kilix highlighted the tournament with digital content designed to extend its adult nicotine consumer reach beyond the event itself. Planned as a multi year platform, we believe the onvitational can become a signature brand experience that builds lasting equity and further differentiates on over time.

These efforts are grounded in responsibility with safeguards to limit reach to
underage audiences and a strong focus on regulatory compliance. We're encouraged by the progress Helix has made so far this year and the foundation it is building for future growth. With a broader onplus portfolio, premium retail visibility, and growing brand equity. We continue to believe AN is well positioned to compete and drive long term profitable growth in the category.

From a regulatory perspective, the FDA's enforcement guidance allowed Helix to move through the
regulatory process more efficiently. However, guidance can change. Sustained progress on harm reduction requires a more durable foundation, an efficient and predictable authorization process established through rulemaking. That's why Helix and Enjoy brought legal action against the FDA during the quarter. The complaint asked the court to require the FDA to establish a review process that meets the 180 day timeframe set by Congress and to allow our products with applications pending beyond that time frame to be in market while the agency puts a new process in place.

Following the filing, the FDA announced plans to evaluate changes to the PMTA framework. The agency acknowledged
challenges it has faced implementing the 2021 PMTA rule, including the widespread growth ?of the illicit market and slow pace of new product authorizations and intends to pursue new rulemaking. ?We welcome this development and believe the modernized framework that maintains a high bar with rigorous standards for new products and provides greater clarity, predictability, and efficiency is critical to advancing the long-term harm reduction opportunity.

A more efficient authorization process must be paired with consistent illicit product enforcement. On that front, we continue to see encouraging progress on illicit e vapor enforcement as federal, state, and local policymakers and law
enforcement take meaningful steps to close gaps and hold bad actors accountable across the supply chain. These enforcement efforts appear to be impacting e-vapor category dynamics. At the end of September, we estimate there were approximately 20 million adult vapors, down one million versus year ago, primarily driven by fewer e-vapor consumers using illicit products.

Ultimately, we believe sustained enforcement and a more efficient authorization process
are both necessary to establish a level playing field for legal manufacturers and expand access to high quality smoke free products for adult nicotine consumers. We remain confident in the opportunities in front of ?us, the breadth of our portfolio, the passion of our talented employees, our manufacturing capabilities, ?and the financial flexibility supported by PMUSA's import export activity, position us to deliver strong shareholder returns while investing for the future.

With that, I'll turn the call over to Heather to provide additional details on our business
and financial results.

Passages & reports (25)
  • We believe these additions strengthened the ONPLUS portfolio and are supporting it with su…
  • its volume. In an increasingly competitive category, we believe this positioning provides …
  • creating distinctive consumer experiences. Earlier this month, Helix hosted the inaugural …
  • The
  • event gave on consumers the chance to compete alongside athletes and golf personalities. K…
  • Planned as a multi year platform, we believe the onvitational can become a signature brand…
  • underage audiences and a strong focus on regulatory compliance. We're encouraged by the pr…
  • visibility, and growing brand equity. We continue to believe AN is well positioned to comp…
  • regulatory process more efficiently. However, guidance can change. Sustained progress on h…
  • Helix and Enjoy brought legal action against the FDA during the quarter. The complaint ask…
  • applications pending beyond that time frame to be in market while the agency puts a new pr…
  • challenges it has faced implementing the 2021 PMTA rule, including the widespread growth
  • of
  • the illicit market and slow pace of new product authorizations and intends to pursue new r…
  • We
  • welcome this development and believe the modernized framework that maintains a high bar wi…
  • A more efficient authorization process must be paired with consistent illicit product enfo…
  • enforcement take meaningful steps to close gaps and hold bad actors accountable across the…
  • approximately 20 million adult vapors, down one million versus year ago, primarily driven …
  • are both necessary to establish a level playing field for legal manufacturers and expand a…
  • us,
  • the breadth of our portfolio, the passion of our talented employees, our manufacturing cap…
  • and
  • the financial flexibility supported by PMUSA's import export activity, position us to deli…
  • and financial results.

Speaker 3

Unverified voice label

Thanks, Al, and good morning, everyone. Altre's operating companies effectively executed their strategies and delivered impressive third-quarter and first nine months financial performance. Adjusted diluted earnings per share increased 4.8% in the third quarter and by 5.1% for the first nine months. We delivered these results in an environment of continued economic pressure on adult smokers. The overall cost of goods and services has risen roughly 30% since 2021, putting sustained pressure on household budgets, while more recent increases in gas prices have further constrained discretionary income.

Against this backdrop, the smokable products segment remained the key contributor to earnings growth. Our smokable strategy is to maximize profitability over the long term while balancing investments in Marlboro and funding the growth
of smoke-free products. PMUSA's portfolio approach supports this strategy by offering options across brands and price points while driving strong financial results. Adjusted operating companies' income grew by 3.9% to $3.1 billion in the third quarter and by 4.1% to $8.8 billion for the first nine months.

Adjusted OCI margins expanded to 64.5% for the third quarter and 64.8% for the first nine months, up 0.1 percentage point and
0.4 percentage points respectively. Price realization was 4.4% for the quarter, reflecting the mixed impact of both Marlboro Cowboy Cut and Basics volume growth. Smokable volumes declined remained moderate. Reported domestic cigarette volumes declined by 2.9% in the third quarter and 2.8% for the first nine months.

When adjusted for trade inventory movements, we estimate domestic cigarette volumes for the third quarter and for the first nine months declined by 4%, slightly below an estimated 5%
decline for the industry. Within the highly profitable premium segment, Marlboro strengthened its longstanding leadership position. ?The introduction of Cowboy Cut provided price-sensitive Marlboro smokers with a premium option in a challenging economic environment, contributing to Marlboro's share performance in the third quarter.

Marlboro expanded its share premium segment to 60%, up three tenths versus the prior year and four
tenths sequentially. Marlboro's overall retail share was unchanged sequentially and down one share point versus the year ago period as economic pressures continue to drive discount segment growth. ?In the third quarter, discount retail share grew by two share points and is now 34.1% of the category. BASIC continues to support PMUSA's RGM strategy by providing a competitive offering in stores where discount brands are most relevant.

During
the quarter, BASIC's retail share expanded by three-tenths sequentially and 1.8 share points year over year. The combined performance of Marble and BASIC reflects the effectiveness of PMUSA's total portfolio approach. Total PMUSA retail share expanded two-tenths of a share point sequentially and three-tenths versus a year ago. In cigars for the third quarter and first nine months, reported shipment volume increased 0.9% and 2%, respectively, as Middleton continued to significantly outperform in a declining large mass cigar industry.

Let's now turn to the oral tobacco product segment. Financial results reflect reflect continued investment behind ONPLUS and the impact of lower MST volumes. Adjusted OCI decreased by 3.7% to
$443 million in the third quarter and by 4% to $1.3 billion for the first nine months. Adjusted OCI margins remain strong at 66.4% for the third quarter and 66.8% for the first nine months.

Total segment
reported shipment volume decreased 4.3% for the third quarter and 5.4% for the first nine months, as growth in on was more than offset by the lower MST volumes. When adjusted for trade inventory movements, we estimate third quarter and first nine months oral tobacco product segment volumes both declined by an estimated 5%. Oral tobacco products segment retail share was 27.9% for the third quarter and 28.6% for the first nine months. ?

In
the highly profitable moist smokeless tobacco segment, Copenhagen maintained its longstanding premium leadership. Turning to ABI's financial results, we recorded $191 million of adjusted equity earnings in the third quarter, up 21.7% versus the prior year. We continue to view our ABI stake as a financial investment, and our goal remains to maximize the long term value of the investment for our shareholders. Our strong financial performance for the first nine months enabled us to return over $6 billion to our shareholders, including $5.3 billion in dividends and $735 million in share repurchases.

We remain committed to providing significant cash returns to our shareholders, as demonstrated by our recent dividend increase. In August, our board increased our quarterly dividend by
4.7% to $1.11 per share, our 61st increase in 57 years, and consistent with our progressive dividend goal of mid single digit annual growth. And today, we announced that our board authorized a billion dollar expansion of our existing share repurchase program, which now expires on December 31st, 2027.

In addition, our balance sheet remains strong.
?Our debt to EBITDA ratio as of September 30th was 1.9 times, in line with our target of approximately two times. Finally, let's turn to our financial outlook. Our businesses performed extremely well in a dynamic environment during the first nine months of the year, and we maintained the strength of our core tobacco businesses while investing towards our vision.

As a result, we raised our earnings guidance and now expect to deliver adjusted diluted EPS in a range of $5.66 to $5.74, representing a growth rate
of 4.5% to 6% from a base of $5.42 in 2025. With that, we'll wrap up and Sal and I will be happy to take your questions. While the calls are being compiled, I'll remind you today's earnings release and our non-gap reconciliations are available on outria.com.

We've also posted our quarterly metrics, which include pricing, inventory, and other items. Operator, let's open the question and answer period.

Passages & reports (30)
  • Thanks, Al, and good morning, everyone. Altre's operating companies effectively executed t…
  • the first nine months. We delivered these results in an environment of continued economic …
  • gas prices have further constrained discretionary income. Against this backdrop, the smoka…
  • of smoke-free products. PMUSA's portfolio approach supports this strategy by offering opti…
  • third quarter and by 4.1% to $8.8 billion for the first nine months. Adjusted OCI margins …
  • 0.4 percentage points respectively. Price realization was 4.4% for the quarter, reflecting…
  • declined by 2.9% in the third quarter and 2.8% for the first nine months. When adjusted fo…
  • decline for the industry. Within the highly profitable premium segment, Marlboro strengthe…
  • The
  • introduction of Cowboy Cut provided price-sensitive Marlboro smokers with a premium option…
  • tenths sequentially. Marlboro's overall retail share was unchanged sequentially and down o…
  • In
  • the third quarter, discount retail share grew by two share points and is now 34.1% of the …
  • the quarter, BASIC's retail share expanded by three-tenths sequentially and 1.8 share poin…
  • two-tenths of a share point sequentially and three-tenths versus a year ago. In cigars for…
  • in a declining large mass cigar industry. Let's now turn to the oral tobacco product segme…
  • $443 million in the third quarter and by 4% to $1.3 billion for the first nine months. Adj…
  • reported shipment volume decreased 4.3% for the third quarter and 5.4% for the first nine …
  • oral tobacco product segment volumes both declined by an estimated 5%. Oral tobacco produc…
  • In
  • the highly profitable moist smokeless tobacco segment, Copenhagen maintained its longstand…
  • prior year. We continue to view our ABI stake as a financial investment, and our goal rema…
  • including $5.3 billion in dividends and $735 million in share repurchases. We remain commi…
  • 4.7% to $1.11 per share, our 61st increase in 57 years, and consistent with our progressiv…
  • which now expires on December 31st, 2027. In addition, our balance sheet remains strong.
  • Our
  • debt to EBITDA ratio as of September 30th was 1.9 times, in line with our target of approx…
  • maintained the strength of our core tobacco businesses while investing towards our vision.…
  • of 4.5% to 6% from a base of $5.42 in 2025. With that, we'll wrap up and Sal and I will be…
  • are available on outria.com. We've also posted our quarterly metrics, which include pricin…

Speaker 0

Thank you. At this time, if you would like to ask a question, please click on the raise hand button, which can be found on the black bar at the bottom of your screen. When it is your turn, you will receive a message on your screen from the host allowing you to talk, and then you will hear your name called. Please accept, unmute your audio, and ask your question.

Investors, analysts, and media representatives are now invited to participate in the question and answer session. We will take questions from the investment community first. The first question is from FarmBeg

Passages & reports (2)
  • Thank you. At this time, if you would like to ask a question, please click on the raise ha…
  • then you will hear your name called. Please accept, unmute your audio, and ask your questi…

Questions & answers

Speaker 0

at UBS. Please unmute yourself and begin with your question.

Passages & reports (1)
  • at UBS. Please unmute yourself and begin with your question.

Speaker 4

Unverified voice label

Good morning, Sal. Hey Heather, how are you? Couple of questions from me, please. Firstly, on industry cigarette volumes and ?then on Marlborough Cowboy Cut. So on the industry, the volumes have remained pretty resilient this year. And it looks like the sequential growth ?in the discount segment moderated somewhat this quarter despite ?the higher gasoline prices. Are there any particular factors you ?would call out behind the resilience?

And more broadly, are you seeing any evidence that the pressure on the smoker is beginning to ease?
?And then second, secondly, on cowboy car, can you can you maybe help us understand where you ?see the subrance positioning within the broader Marlboro portfolio? I know initially it was launched at a discount to Marlboro Black, but we're we're now seeing it priced above black in some states, while while in other states it's sort of yet to ?be introduced.

Um, how should we think about the positioning and and the intended role of cowboy cut longer term? Thank

Passages & reports (15)
  • Good morning, Sal. Hey Heather, how are you? Couple of questions from me, please. Firstly,…
  • then
  • on Marlborough Cowboy Cut. So on the industry, the volumes have remained pretty resilient …
  • in
  • the discount segment moderated somewhat this quarter despite
  • the
  • higher gasoline prices. Are there any particular factors you
  • would
  • call out behind the resilience? And more broadly, are you seeing any evidence that the pre…
  • And
  • then second, secondly, on cowboy car, can you can you maybe help us understand where you
  • see
  • the subrance positioning within the broader Marlboro portfolio? I know initially it was la…
  • be
  • introduced. Um, how should we think about the positioning and and the intended role of cow…

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 2

Yeah, terrific. And and thanks for your questions. Two really good questions. So let's start with the industry volume. Um, you know, the consumer continues to be under economic pressure, no doubt. The uh the inflation, which has been in place for multiple years, continues to put pressure on their everyday goods. I would say, though, that nicotine historically has been a little bit more resilient than other CPG categories for sure.

But when you look at the moderation of the decline rates that you're seeing in the cigarette category,
that's primarily being driven by the lower cross category movement from the illicit e vapor category. And I would say probably two factors are driving that. One is these products have been in the market for multiple years now, so consumers that were interested in it have moved. ?

And
then the second factor is, as we talked about earlier, the uh the focus on enforcement for illicit uh products. Um we think that is having some impact. Now we need that those efforts to be sustained and to continue, but it's definitely having an impact on supply chain and in our minds. As far as Cowboy Cut, ?uh let's start with the smokable strategy, which is to maximize profitability over the long term and balance investments in Marlboro with investments in our long term vision.

Cowboy Cut uh provides a premium Marlboro option at the right right price to retain
value-sensitive smokers within that franchise. It it delivers a classic Marlboro experience and is supported by brand equity that draws on its American heritage and complements the nation's 250th celebration. It's pretty widely distributed. It's in about 100,000 stores, which is about 75% of the cigarette volume. And it it's it's a a strategy we've deployed before.

You know, we've seen it with Marlboro Special Select, you've seen it with Marlboro Black, where you have introductory pricing, and then you will see PMUSA
take pricing or margin up those SKUs over ?time. Um obviously, you know, you talked about different states and different pricing. Well, that that's reflective of the data analytics and RGM tools that PMUSA has been able to deploy.

So we're really, really pleased with the impact on Marlboro. You saw Marlboro's sharehold premium has
reached about 60%. It's three tenths year over year. So feel really good about the overall performance of our smokable segment and the cigarette category in particular.

Passages & reports (15)
  • Yeah, terrific. And and thanks for your questions. Two really good questions. So let's sta…
  • continues to put pressure on their everyday goods. I would say, though, that nicotine hist…
  • that's primarily being driven by the lower cross category movement from the illicit e vapo…
  • were interested in it have moved.
  • And
  • then the second factor is, as we talked about earlier, the uh the focus on enforcement for…
  • on supply chain and in our minds. As far as Cowboy Cut,
  • uh
  • let's start with the smokable strategy, which is to maximize profitability over the long t…
  • value-sensitive smokers within that franchise. It it delivers a classic Marlboro experienc…
  • in about 100,000 stores, which is about 75% of the cigarette volume. And it it's it's a a …
  • take pricing or margin up those SKUs over
  • time.
  • Um obviously, you know, you talked about different states and different pricing. Well, tha…
  • reached about 60%. It's three tenths year over year. So feel really good about the overall…

Speaker 4

Thank

Passages & reports (1)
  • Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 2

Sure.

Passages & reports (1)
  • Sure.

Speaker 0

The next question is from Matt Smith at Stifle. Please unmute yourself and begin with your question.

Passages & reports (1)
  • The next question is from Matt Smith at Stifle. Please unmute yourself and begin with your…

Speaker unclear

?Hi,

Passages & reports (1)
  • Hi,

Speaker 5

Unverified voice label

good morning. Just wanted to come back to the ?raise of the full year guidance for EPS. Can you talk about where you're seeing strength relative to your previous expectations? ?And have you stepped up your investment levels behind some of the initiatives, whether it's behind the smoke-free vision investments or in combustible, and leaned into the volume opportunity that becomes the future pricing opportunity over time.

Thank

Passages & reports (5)
  • good morning. Just wanted to come back to the
  • raise
  • of the full year guidance for EPS. Can you talk about where you're seeing strength relativ…
  • And
  • have you stepped up your investment levels behind some of the initiatives, whether it's be…

Speaker unclear

?you. Okay,

Passages & reports (1)
  • you. Okay,

Speaker 3

Matt, thanks for the question. Um, just as a reminder, in the beginning of the year, we did have our guidance range two and a half to five percent. And as we performed really strongly through the first nine months, it's given us confidence to not only narrow but raise the guidance to the four and a half to six. I will say that's inclusive of investments that we tend to invest in our smoke free vision, um, really around on plus.

And you're starting to see that play out in the marketplace with the 12 milligram product as well as our flavor line extensions.
?You know, the other thing that we're mindful of is that we continue to be challenged by a pretty difficult macroeconomic environment for the consumer. We feel great about our RGM capabilities to manage through that environment as they remain under pressure.

Gas prices are still elevated. Sal's already talked about
inflation, but this new guidance range of the four and a half to six percent, we feel really confident that we can deliver throughout the rest of the year.

Passages & reports (5)
  • Matt, thanks for the question. Um, just as a reminder, in the beginning of the year, we di…
  • and a half to six. I will say that's inclusive of investments that we tend to invest in ou…
  • You
  • know, the other thing that we're mindful of is that we continue to be challenged by a pret…
  • inflation, but this new guidance range of the four and a half to six percent, we feel real…

Speaker 5

Appreciate that, Heather. And a follow-up on the quarter. Duty drawback, I think was $124 million revenue benefit. Previously, you talked about it being pretty equally phased in the second half of the year. Does ?that is is the third quarter level a reasonable amount for the fourth quarter? I know there's some catch-up timing in there. I'll pass it on after that. Thank

Passages & reports (3)
  • Appreciate that, Heather. And a follow-up on the quarter. Duty drawback, I think was $124 …
  • that
  • is is the third quarter level a reasonable amount for the fourth quarter? I know there's s…

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 3

Yeah, I appreciate it. Um, our expectations have not changed. We did have some slight benefit in Q2 from a timing of the FET credit that we benefited from in Q3, but our expectations for the second half of the year in terms of stepping up and being balanced between the quarters has not changed.

Passages & reports (1)
  • Yeah, I appreciate it. Um, our expectations have not changed. We did have some slight bene…

Speaker 0

The next question is from Bonnie Herzog at Goldman Sachs. Please unmute yourself and begin with your question.

Passages & reports (1)
  • The next question is from Bonnie Herzog at Goldman Sachs. Please unmute yourself and begin…

Speaker 6

Unverified voice label

All right. Thank you. Good morning, everyone. I um had a quick follow-up on what you just touched on, Heather. In terms of the um double duty drawback benefit, you did export 10% of your sig volume in Q3. So I guess I was hoping to hear a little more color on how we should think about your ability to ramp this further next year, especially given your contract manufacturing agreement with Philip Morris will kick in.

So if you could talk about that also, that would be appreciated.

Passages & reports (2)
  • All right. Thank you. Good morning, everyone. I um had a quick follow-up on what you just …
  • think about your ability to ramp this further next year, especially given your contract ma…

Speaker 3

Yeah, thank you, Bonnie. Good morning. So in the first half of the year, we were really establishing the contract manufacturing arrangements, and then we communicated that step up balanced approach through the second half of the year without getting too far ahead in terms of expectations for 2027. You are right to call out that that PMI agreement does not start until 2027. And so that benefit will certainly kick in.

What we're working against, and where you see the increase from Q2 to Q3 is our current CMA arrangements. And again, without getting too far ahead, we expect to be pretty
balanced across the Q3 and Q4 here.

Passages & reports (3)
  • Yeah, thank you, Bonnie. Good morning. So in the first half of the year, we were really es…
  • You are right to call out that that PMI agreement does not start until 2027. And so that b…
  • balanced across the Q3 and Q4 here.

Speaker 6

Okay. And then maybe if I could just switch gears a bit and I have a question on vapor, which you touched on, but you know, just in terms of Enjoy ACE, I believe you've addressed the patent infringement issues and you're able to bring the product back to the market. So curious if you're planning on doing this, you know, maybe soon and how you're thinking about what role, you know, vapor can ultimately play in your smoke-free portfolio.

And then if or when you bring it back to the market, I guess I'm trying to understand how you're gonna manage it. I mean, would you manage it differently
or run the business differently than what you had done before? Because I'm thinking about the substantial operating losses you used to have on the brand. Thank

Passages & reports (3)
  • Okay. And then maybe if I could just switch gears a bit and I have a question on vapor, wh…
  • planning on doing this, you know, maybe soon and how you're thinking about what role, you …
  • or run the business differently than what you had done before? Because I'm thinking about …

Speaker unclear

?you. Yeah,

Passages & reports (1)
  • you. Yeah,

Speaker 2

good morning, Bonnie. Um, you are correct to point out that we have worked around the patent issues uh that that uh forced us to pull Enjoy ACE out of the market. We have not announced when we're going back in the market, but we do plan on being back in the uh e vapor market. Um you're also right to point out that um our approach is going to be, I would say, I ?would characterize it as very disciplined.

The market, while we've seen some improvement, is still predominant predominantly uh driven by the illicit category. And we want to compete in the market, but we want to do it in a disciplined way and in a profitable
way over time. So for us, we continue to engage with stakeholders to drive enforcement activity, to maintain or sustain ?it over time. We also recognize that it's important for the FDA to authorize products more quickly.

We also recognize that there are certain attributes related to the illicit category that appeal to the consumers. So if you think about our
innovative pipeline, we want ?to delight the consumer over time. So we continue to innovate further on Android ACE. But our approach will be disciplined and uh we'll have more to say uh as as time proceeds.

Passages & reports (10)
  • good morning, Bonnie. Um, you are correct to point out that we have worked around the pate…
  • vapor market. Um you're also right to point out that um our approach is going to be, I wou…
  • would
  • characterize it as very disciplined. The market, while we've seen some improvement, is sti…
  • way over time. So for us, we continue to engage with stakeholders to drive enforcement act…
  • it
  • over time. We also recognize that it's important for the FDA to authorize products more qu…
  • innovative pipeline, we want
  • to
  • delight the consumer over time. So we continue to innovate further on Android ACE. But our…

Speaker 6

All right, thank you. I'll pass it

Passages & reports (1)
  • All right, thank you. I'll pass it

Speaker unclear

?on.

Passages & reports (1)
  • on.

Speaker 2

Welcome.

Passages & reports (1)
  • Welcome.

Speaker 0

The next question is from Andre Andon at Jeffries. Please unmute yourself and begin with your question.

Passages & reports (1)
  • The next question is from Andre Andon at Jeffries. Please unmute yourself and begin with y…

Speaker unclear

?Hi,

Passages & reports (1)
  • Hi,

Speaker 4

good morning Sal, Heather, and Mac. Thank you very much for taking my questions. Uh two from me, please.

Passages & reports (1)
  • good morning Sal, Heather, and Mac. Thank you very much for taking my questions. Uh two fr…

Speaker 7

Unverified voice label

Firstly, ?uh following

Passages & reports (3)
  • Firstly,
  • uh
  • following

Speaker 4

up

Passages & reports (1)
  • up

Speaker 7

to

Passages & reports (1)
  • to

Speaker 4

Bonnie's question on vapes,

Passages & reports (1)
  • Bonnie's question on vapes,

Speaker 7

we've already seen a legal competitor launch flavored vapes in August, September this year. Where do you see such products, uh legal flavored vapes, potentially gaining share? Are they more likely to be a pressure point on cigarettes or rather on illicit vapes? And then secondly, it's encouraging to see on grow year on year in Q3, but I believe ?the volumes have still declined relative to the previous quarter to Q226.

What your expectations for volume growth for on into next quarter and into next year? And what would underpin this? Thank

Passages & reports (4)
  • we've already seen a legal competitor launch flavored vapes in August, September this year…
  • in Q3, but I believe
  • the
  • volumes have still declined relative to the previous quarter to Q226. What your expectatio…

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 2

Yeah, so um let me start with your your vapor question. And it's a good one. Look, um, e-vapor is a far lower risk proposition for smokers and exposes uh those uh those smokers to lower levels of smoking. So we believe e-vapor continues to play an important role in long-term harm reduction. We also recognize that flavors is something that attracts smokers to a less harmful product.

So we do think it plays a role. But as I as we said, the
category itself is upside down. The risk of consumers using illicit vapors, which have not been through the regulatory process, threatens uh the long-term tobacco harm reduction opportunity. And so we continue to engage with our stakeholders, as I said earlier, to drive the illicit uh enforcement. And we have seen definitely a stepped up level of enforcement.

So over the long term, we believe vapor does play an important role and we will participate in that. Um your question on uh growth of the nicotine pouch.

Passages & reports (4)
  • Yeah, so um let me start with your your vapor question. And it's a good one. Look, um, e-v…
  • believe e-vapor continues to play an important role in long-term harm reduction. We also r…
  • category itself is upside down. The risk of consumers using illicit vapors, which have not…
  • to drive the illicit uh enforcement. And we have seen definitely a stepped up level of enf…

Look, um, the volume decline you're seeing is primarily driven actually by the MST category as consumers move from MST into the nicotine pouch category. We're really excited about on plus. We believe that the NICOSilk technology for the pouch is a differentiator. But we also recognize that higher uh levels of nicotine and flavors drive a lot of the consumer growth. So we're excited that we've got 12 milligrams, just went into the market recently.

So you haven't really seen the impact of that on retail share
yet. And then we are entering the category, the uh the retail space with uh flavors, mango pineapple, and blueberry mint. We announced watermelon mint coming in November in select stores. And uh we plan on having future innovation through flavor deliveries uh in the future. So we're excited about the pipeline. We're excited about the tobacco harm reduction opportunity that nicotine pouch provides the adult nicotine consumers.

So, you know, we we we look forward to uh onPlus and on
Classic continuing to play a role in

Passages & reports (5)
  • Look, um, the volume decline you're seeing is primarily driven actually by the MST categor…
  • a differentiator. But we also recognize that higher uh levels of nicotine and flavors driv…
  • yet. And then we are entering the category, the uh the retail space with uh flavors, mango…
  • deliveries uh in the future. So we're excited about the pipeline. We're excited about the …
  • Classic continuing to play a role in

Speaker unclear

?that.

Passages & reports (1)
  • that.

Speaker 7

Understood. Thank you very

Passages & reports (1)
  • Understood. Thank you very

Speaker unclear

?much.

Passages & reports (1)
  • much.

Speaker 2

Welcome.

Passages & reports (1)
  • Welcome.

Speaker 0

Just a reminder if you would like to ask a question, please click on the raise hand button, which can be found on the black bar at the bottom of your screen. The next question is from Palavmetal at Barclays. Please unmute yourself and begin with your question.

Passages & reports (1)
  • Just a reminder if you would like to ask a question, please click on the raise hand button…

Speaker 4

Hi, uh, good morning.

Passages & reports (1)
  • Hi, uh, good morning.

Speaker unclear

?So just

Passages & reports (1)
  • So just

Speaker 1

to follow

Passages & reports (1)
  • to follow

Speaker unclear

?up on volumes, uh see,

Passages & reports (1)
  • up on volumes, uh see,

Speaker 7

volumes are up 13% by

Passages & reports (1)
  • volumes are up 13% by

Speaker 4

over in the third quarter. But when I look at scanner data, it ?is down mid-teens or something like ?that. So is there a significant inventory as you roll out 12 mg or is it something else?

Passages & reports (5)
  • over in the third quarter. But when I look at scanner data, it
  • is
  • down mid-teens or something like
  • that.
  • So is there a significant inventory as you roll out 12 mg or is it something else?

Speaker unclear

?You

Passages & reports (1)
  • You

Speaker 1

know,

Passages & reports (1)
  • know,

Speaker 2

I wouldn't say significant, but I would say, you know, there's obviously some pipeline inventory as we uh launch the 12 milligram across um mint, ?uh wintergreen, and tobacco. And then you've got the flavor introductions that we talked about earlier. You know, there's some uh differences on how you read scan and data, or where they look at pouches versus cans. So there's a little bit of noise in that, but nothing significant.

But you know, within a
quarter, you're going to have some pipeline movement, not just for us. You have other brands introducing new SKUs as well. So ?I think you got to look at that over a longer period of

Passages & reports (6)
  • I wouldn't say significant, but I would say, you know, there's obviously some pipeline inv…
  • uh
  • wintergreen, and tobacco. And then you've got the flavor introductions that we talked abou…
  • quarter, you're going to have some pipeline movement, not just for us. You have other bran…
  • I
  • think you got to look at that over a longer period of

Speaker unclear

?time.

Passages & reports (1)
  • time.

Speaker 4

Sure. And if I can then ask on ?your cigarette business, okay. And if I exclude the double UT drawback

Passages & reports (3)
  • Sure. And if I can then ask on
  • your cigarette business, okay.
  • And if I exclude the double UT drawback

Speaker unclear

?for a moment,

Passages & reports (1)
  • for a moment,

Speaker 7

then the EBIT ?on your core cigarette business is flat,

Passages & reports (3)
  • then the EBIT
  • on your core cigarette
  • business is flat,

Speaker unclear

?despite cigarette volumes

Passages & reports (1)
  • despite cigarette volumes

Speaker 4

being much better than what anyone of us would have thought at the start of the year. So how should we think about that? And how do you plan to grow your cigarette profits? Uh, especially as cigarette volumes start lapping tougher comps over the next few months?

Passages & reports (1)
  • being much better than what anyone of us would have thought at the start of the year. So h…

Speaker 2

Yeah, I I think it's frankly a little unfair to pick out one aspect of the margin and pull it out and say, well, EBIT is flat, or you know, you got to look across the entire mark composition of the margin, which is driven by pricing, cost management, duty drawback is part of it. We feel really good about our ability to grow income within the cigarette category.

You know, we get strong OCI performance for the first nine months. You've seen Marlboro perform really well in the highly profitable
premium segment. PMUSA's overall share has grown through the total portfolio approach. And so we, you know, we feel we feel really good about the smokable segment in general. And as Heather stated earlier, that confidence and that performance through the first nine months allowed us to raise guidance, and we were happy to provide that as well.

So feel really good about the business overall. But thanks for the question.

Passages & reports (4)
  • Yeah, I I think it's frankly a little unfair to pick out one aspect of the margin and pull…
  • pricing, cost management, duty drawback is part of it. We feel really good about our abili…
  • premium segment. PMUSA's overall share has grown through the total portfolio approach. And…
  • that performance through the first nine months allowed us to raise guidance, and we were h…

Speaker unclear

?Sure,

Passages & reports (1)
  • Sure,

Speaker 4

and if I can just squeeze

Passages & reports (1)
  • and if I can just squeeze

Speaker unclear

?one

Passages & reports (1)
  • one

Speaker 7

more in on duty drawback. Uh you are exiting the year

Passages & reports (1)
  • more in on duty drawback. Uh you are exiting the year

Speaker 4

at around 500 million annual uh benefit from duty drawback ?uh based on the current run rate. And then as I think about next year, uh you will probably ramp up the current program and then the PM uh contract agreement will also kick ?in. So can you give us a broad range? I mean, from 500 million, can it go to a billion, or are we looking at something around 700, 800 million for next year?

Passages & reports (5)
  • at around 500 million annual uh benefit from duty drawback
  • uh
  • based on the current run rate. And then as I think about next year, uh you will probably r…
  • in.
  • So can you give us a broad range? I mean, from 500 million, can it go to a billion, or are…

Speaker 2

No, it we're not providing that range. Um, I I understand the question. Uh I'd remind you, as Heather said earlier, you are not seeing the impact of the uh the contract manufacturing agreement with PMI yet. That'll happen next year. So we talked about that this volume does build over time. Um, I think Heather laid laid it out really well in earlier questions and in her remarks.

So but we won't provide any further guidance on

Passages & reports (2)
  • No, it we're not providing that range. Um, I I understand the question. Uh I'd remind you,…
  • volume does build over time. Um, I think Heather laid laid it out really well in earlier q…

Speaker unclear

?that.

Passages & reports (1)
  • that.

Speaker unclear

?Sure.

Passages & reports (1)
  • Sure.

Speaker 4

Thank

Passages & reports (1)
  • Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 2

Welcome.

Passages & reports (1)
  • Welcome.

Speaker 0

And the final question is from Eric Sarota at Morgan Stanley. Please unmute yourself and begin with your question.

Passages & reports (1)
  • And the final question is from Eric Sarota at Morgan Stanley. Please unmute yourself and b…

Speaker 1

Great.

Passages & reports (1)
  • Great.

Speaker 7

Thanks for taking the questions. A couple of things. First, Sal, can

Passages & reports (1)
  • Thanks for taking the questions. A couple of things. First, Sal, can

Speaker unclear

?I get your perspective a little bit in terms of uh nicotine pouch category growth over the uh shorter term and then over the mid to long term

Passages & reports (1)
  • I get your perspective a little bit in terms of uh nicotine pouch category growth over the…

Speaker 7

seeing an incredible amount of innovation from both Ultra Helix and um and and your competitors over the past four or five months as the regulatory environment has changed. At the same time, the category growth rate hasn't really materially accelerated. Um, uh coming up, you're going to have the leader

Passages & reports (2)
  • seeing an incredible amount of innovation from both Ultra Helix and um and and your compet…
  • accelerated. Um, uh coming up, you're going to have the leader

Speaker unclear

?in the category, you know, effectively lowering the price per pouch. You

Passages & reports (1)
  • in the category, you know, effectively lowering the price per pouch. You

Speaker 7

know,

Passages & reports (1)
  • know,

Speaker unclear

?how do you see this all playing out in

Passages & reports (1)
  • how do you see this all playing out in

Speaker 7

terms ?of category uh

Passages & reports (3)
  • terms
  • of
  • category uh

Speaker unclear

?volume and uh revenue growth over the short term? And then

Passages & reports (1)
  • volume and uh revenue growth over the short term? And then

Speaker 7

any change to your thinking about how big this category can be over the mid to long term?

Passages & reports (1)
  • any change to your thinking about how big this category can be over the mid to long term?

Speaker 2

Yeah, look, um, it's a really good question. The nicotine pouch category has seen tremendous growth, much of it driven by MST consumers that move into nicotine pouch. There are a number of reasons for that, including social friction. ?Uh, if you think about, you know, there's no spitting as an example with nicotine pouch. Um, you've also seen some growth from cigarette consumers that are seeking a reduced harm uh way of enjoying nicotine if you ?will um the the rate of acceleration you know it look it as the numbers get bigger uh like any category you would see that the percentage change might not be as high as when you're first seeing the adoption obviously so that's that's something to consider but um ?you know we see the category as a tremendous tobacco harm reduction opportunity.

Um it's still predominantly male. I think if you look overseas, you have seen women and other demographics uh adopt the product. So we think that's continues to be an opportunity. And you're right to
point out it is a highly competitive category. You know, it's it's a growing category. So you're gonna see uh competition, and ?you know, we're used to that. I mean, the cigarette category has been highly competitive, the smokeless category was highly competitive.

But we believe over the long term, tobacco like margins are very achievable in this category. We see on and on plus as is a premium proposition. We continue to
invest in the pipeline of innovation. We continue to invest in the brand. We were really excited to see the on votational take place. So we feel really good about the category and the potential it has for work long term harm reduction in the US market.

Passages & reports (12)
  • Yeah, look, um, it's a really good question. The nicotine pouch category has seen tremendo…
  • Uh,
  • if you think about, you know, there's no spitting as an example with nicotine pouch. Um, y…
  • will
  • um the the rate of acceleration you know it look it as the numbers get bigger uh like any …
  • you
  • know we see the category as a tremendous tobacco harm reduction opportunity. Um it's still…
  • point out it is a highly competitive category. You know, it's it's a growing category. So …
  • you know,
  • we're used to that. I mean, the cigarette category has been highly competitive, the smokel…
  • invest in the pipeline of innovation. We continue to invest in the brand. We were really e…
  • US market.

Speaker unclear

?Great. And then a quick follow

Passages & reports (1)
  • Great. And then a quick follow

Speaker 4

up. Just turning to your

Passages & reports (1)
  • up. Just turning to your

Speaker unclear

?slide on the industry volume

Passages & reports (1)
  • slide on the industry volume

Speaker 7

decomposition for cigarettes. The price elasticity impact ticked down about 20 basis points over the past quarter. What do you think is driving that? And then additionally, the

Passages & reports (1)
  • decomposition for cigarettes. The price elasticity impact ticked down about 20 basis point…

Speaker unclear

?macro cross category and other uh continues to tick lower. I I know uh you called out uh cross category at less than 50 basis points versus about 50 basis points. So maybe there's just some some rounding

Passages & reports (1)
  • macro cross category and other uh continues to tick lower. I I know uh you called out uh c…

Speaker 4

here,

Passages & reports (1)
  • here,

Speaker unclear

?but just

Passages & reports (1)
  • but just

Speaker 7

wondering what's driving the reductions

Passages & reports (1)
  • wondering what's driving the reductions

Speaker unclear

?on uh on on both of those lines.

Passages & reports (1)
  • on uh on on both of those lines.

Speaker 2

Yeah, the the cigarette price elasticity coefficient hasn't changed. It's still negative 0.35. So the impact you're seeing is just a year-over-year price change across the category, if you will. And it's just multiplication, really. As far as the macro and cross-category movement, it's really the cross-category movement and the moderation of that that is lowering that number over time. Macroeconomics still continue to be headwinds, if you will, for the consumer.

It continues to put pressure on consumer spending. Obviously,
we're paying very close attention to that. But as Heather pointed out earlier, our ability to use data analytics and RGM tools, I think, positioned us really well to navigate through that. So PMUSA and the employees there, as well as Helix and UST, continue to use these tools very effectively. And we feel good about our ability to continue to manage through

Passages & reports (4)
  • Yeah, the the cigarette price elasticity coefficient hasn't changed. It's still negative 0…
  • and cross-category movement, it's really the cross-category movement and the moderation of…
  • we're paying very close attention to that. But as Heather pointed out earlier, our ability…
  • continue to use these tools very effectively. And we feel good about our ability to contin…

Speaker unclear

?that.

Passages & reports (1)
  • that.

Speaker 7

Great. Thanks for the questions. I'll pass it on.

Passages & reports (1)
  • Great. Thanks for the questions. I'll pass it on.

Speaker 2

Sure, you're welcome.

Passages & reports (1)
  • Sure, you're welcome.

Speaker unclear

?There

Passages & reports (1)
  • There

Speaker 0

appears to be no further questions at this time. I would like to turn the call back over to MacMethenston for any closing remarks.

Passages & reports (1)
  • appears to be no further questions at this time. I would like to turn the call back over t…

Speaker 1

Thanks to everyone for joining us today. If you have further questions, please feel free to reach out to the IR team. Thanks.

Passages & reports (1)
  • Thanks to everyone for joining us today. If you have further questions, please feel free t…

Speaker 0

This concludes today's call. Thank you for your participation. You may disconnect at any time.

Passages & reports (1)
  • This concludes today's call. Thank you for your participation. You may disconnect at any t…
Source, accuracy & exportsMay contain errorsAccuracy unmeasured. Speakers are anonymous voice labels, local to this call. No names are verified. Section starts and timestamps are inferred. Speakers are anonymous voice labels, local to this call. No names are verified. Section starts and timestamps are inferred.

Short unclear spans may appear inline between matching voice IDs. The ? marker retains unknown attribution; no voice identity is inferred for those words.

AI-generated transcript; names, numbers and wording may be inaccurate.

Speaker IDs are anonymous and local to this call. Section boundaries and timestamps are inferred.

The diarizer reached its eight-speaker limit; distinct voices may share an ID.

Zero-duration alignments: 0. Unassigned words: 210. No alignment has been repaired. Timestamps locate passages in the source recording; decimal positions do not establish word-level precision.

Official issuer source ↗ · Report an issue

Published transcript · Full recording available. Publication updated 2026-11-15T23:59:05.273Z.
Transcript version v1-d8ec1b7cdb4428fd86f0 · publication revision 1. Generated by AI; no listener-verified accuracy score is available.

Dotted spans marked ? have an unclear speaker. They remain unattributed even when shown inside a surrounding turn.

Copy or download
ReadableGrouped by speaker and paragraph with timestamps. Stored words unchanged.
As storedOne line per stored segment with its original speaker ID and start time. Exactly the stored words.
Official issuer source ↗Company overview ↗
TRANSCRIPT FEEDBACK

Report a passage

Your report is queued privately for review. It does not change this transcript automatically. Please avoid personal information.